These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 35435913)
1. Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study. Oberrauch S; Lu J; Cornthwaite-Duncan L; Hussein M; Li J; Rao G; Velkov T J Vis Exp; 2022 Mar; (181):. PubMed ID: 35435913 [TBL] [Abstract][Full Text] [Related]
2. Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System. Chen Y; Mazur C; Luo Y; Sun L; Zhang M; McCampbell A; Tomassy GS J Vis Exp; 2019 Oct; (152):. PubMed ID: 31736489 [TBL] [Abstract][Full Text] [Related]
3. Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections. Metz T; Kuijper EC; van Roon-Mom WMC Methods Mol Biol; 2022; 2434():333-341. PubMed ID: 35213029 [TBL] [Abstract][Full Text] [Related]
4. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration. Monine M; Norris D; Wang Y; Nestorov I J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294 [TBL] [Abstract][Full Text] [Related]
5. [Antibiotic diffusion to central nervous system]. Cabrera-Maqueda JM; Fuentes Rumí L; Valero López G; Baidez Guerrero AE; García Molina E; Díaz Pérez J; García-Vázquez E Rev Esp Quimioter; 2018 Feb; 31(1):1-12. PubMed ID: 29390599 [TBL] [Abstract][Full Text] [Related]
6. Facilitating drug delivery in the central nervous system by opening the blood-cerebrospinal fluid barrier with a single low energy shockwave pulse. Kung Y; Chen KY; Liao WH; Hsu YH; Wu CH; Hsiao MY; Huang AP; Chen WS Fluids Barriers CNS; 2022 Jan; 19(1):3. PubMed ID: 34991647 [TBL] [Abstract][Full Text] [Related]
7. Polymyxins for CNS infections: Pharmacology and neurotoxicity. Velkov T; Dai C; Ciccotosto GD; Cappai R; Hoyer D; Li J Pharmacol Ther; 2018 Jan; 181():85-90. PubMed ID: 28750947 [TBL] [Abstract][Full Text] [Related]
8. Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology. Khani M; Burla GKR; Sass LR; Arters ON; Xing T; Wu H; Martin BA Fluids Barriers CNS; 2022 Jan; 19(1):8. PubMed ID: 35090516 [TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches. Sharma HS; Johanson CE Ann N Y Acad Sci; 2007 Dec; 1122():112-29. PubMed ID: 18077568 [TBL] [Abstract][Full Text] [Related]
10. Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat. Yang Z; Brundage RC; Barbhaiya RH; Sawchuk RJ Pharm Res; 1997 Jul; 14(7):865-72. PubMed ID: 9244142 [TBL] [Abstract][Full Text] [Related]
11. [Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers]. Suzuki H; Sugiyama Y Yakugaku Zasshi; 1994 Dec; 114(12):950-71. PubMed ID: 7869236 [TBL] [Abstract][Full Text] [Related]
12. Understanding the Blood-Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics. de Lange ECM; Hammarlund Udenaes M Clin Pharmacol Ther; 2022 Apr; 111(4):758-773. PubMed ID: 35220577 [TBL] [Abstract][Full Text] [Related]
13. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair. Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949 [TBL] [Abstract][Full Text] [Related]
14. The blood-brain barrier and nasal drug delivery to the central nervous system. Miyake MM; Bleier BS Am J Rhinol Allergy; 2015; 29(2):124-7. PubMed ID: 25785753 [TBL] [Abstract][Full Text] [Related]
15. In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain. Nagaraja TN; Patel P; Gorski M; Gorevic PD; Patlak CS; Fenstermacher JD Cerebrospinal Fluid Res; 2005 Jul; 2():5. PubMed ID: 16045806 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic Modeling of Intrathecal Chemotherapy Pharmacokinetics in the Human Central Nervous System. Li J; Wu A; Kim S Clin Cancer Res; 2024 Apr; 30(7):1397-1408. PubMed ID: 38289997 [TBL] [Abstract][Full Text] [Related]
17. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system. Wu D; Pardridge WM J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978 [TBL] [Abstract][Full Text] [Related]
18. Direct intraventricular delivery of drugs to the rodent central nervous system. DeVos SL; Miller TM J Vis Exp; 2013 May; (75):e50326. PubMed ID: 23712122 [TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system. Zlokovic BV; Apuzzo ML Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854 [TBL] [Abstract][Full Text] [Related]
20. Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults. Ng K; Mabasa VH; Chow I; Ensom MH Neurocrit Care; 2014 Feb; 20(1):158-71. PubMed ID: 23090839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]